FDA Investigator Maribeth G Grattan
Maribeth G Grattan has conducted inspections on 30 sites in 6 countries as of 06 May 2013. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
30
Last Inspection Date:
06 May 2013
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America,
Belgium,
Germany,
United Kingdom of Great Britain and Northern Ireland,
France,
Switzerland
FDA Investigators that have inspected at least one site in common with Maribeth G Grattan:
Allison C Hunter,
Allison M Mcgloin,
Althea A Williams,
Amber M Capello Jones,
Amy S Graf,
Anna M Brannen,
Bailey A Uetrecht,
Benjamin J Dastoli,
Benjamin J Smith,
Bernard P Heidt,
Brian P Putz,
Brigitte K Hofmann,
Brigitte Kh Strelnik,
Bryan J Love,
Calvin K Cook,
CDR Sean T Creighton,
Charles L Larson,
Charles M Spyr,
Christina L Bigham,
Christine E Kelley,
Christopher T Middendorf,
Cynthia T Cain,
Dannie E Rowland,
David J Gasparovich,
David P Moorhead,
Debara R Reese,
Elisa A Nickum,
Elizabeth Ll Edwards,
Elizabeth P Kinsella,
Ellen J Tave,
Eric S Pittman,
Frederick M Lochner,
Gam S Zamil,
George G Calafactor,
Gina M Brackett,
Hugh M Mcclure, II,
Isabel Y Espinosa,
James E Szelc,
James R Montero,
Jamie L Dion,
Javonica F Penn,
Joan A Loreng,
Jon P Antoniou,
Joseph R Strelnik,
Joshua P Wireman,
Kathleen D Culver,
Kip J Hanks,
Kristina Mezin,
L Rebeccacrk Clark,
Laiza V Garcia,
Laureen M Geniusz,
Lauren N Howard,
Lauren R Coffey,
Lauren R Collins,
Leslie R Clark,
Lindsey M Schwierjohann,
Lisa R Hilliar,
Logan T Williams,
Lori A Carr,
Lori A Lahmann,
Lynnsey A Renn,
Malik S Qaiser,
Marc A Jackson, Jr,
Maribeth G Niesen,
Mark E Parmon,
Michael E Clark,
Michael K Larson,
Michael P Sheehan,
Myra K Casey,
Patrick B Cummings,
Paul E Stein,
Phillip M Pontikos,
Rafeeq A Habeeb,
Richard L Rutherford,
Richard T Riggie,
Robbie J Alleman,
Robert G Ruff,
Rosanna M Goodrich,
Rosanna M Vaccaro,
Roy C Stephens,
Rterry Bolen,
Ryan J Benedict,
Sargum C Sood,
Shannon A Gregory,
Talmane J Fisher,
Teresa K Kastner,
Thai T Duong,
Thanh M Andrews,
Thomas W Nojek,
Tiki J Dixon,
Vesa Vuniqi,
Wen Ning Chan (Sally),
William D Tingley,
William R Brubaker
Maribeth G Grattan's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more